9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of 9 Meters Biopharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. 9 Meters Biopharma Inc market cap is $0.00.
What is the 52-week high for 9 Meters Biopharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. 9 Meters Biopharma Inc 52 week high is $0.0003 as of October 10, 2025.
What is the 52-week low for 9 Meters Biopharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. 9 Meters Biopharma Inc 52 week low is $0.00 as of October 10, 2025.
What was 9 Meters Biopharma Inc stock price yesterday?
9 Meters Biopharma Inc stock price yesterday was $0.0001.
What is the 50-day moving average of 9 Meters Biopharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. 9 Meters Biopharma Inc 50-day moving average is $0.00.